Musculoskeletal neoplasia: Helping the orthopaedic surgeon establish the diagnosis

Seminars in Musculoskeletal Radiology

Volumn 11, Issue 1, 2007, Pages 3-15

  Parsons III, Theodore W ^a,b,c   Frink, Spencer J ^c   Campbell, Scot E ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Evaluation and staging of neoplasia; Imaging characteristics of musculoskeletal neoplasia; Musculoskeletal neoplasia

Indexed keywords

BONE RADIOGRAPHY; BONE SCINTISCANNING; BONE TUMOR; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MUSCLE TUMOR; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDICS; POSITRON EMISSION TOMOGRAPHY; REVIEW; SURGEON;

BONE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MUSCLE NEOPLASMS; MUSCULOSKELETAL DISEASES; ORTHOPEDICS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35148864077     PISSN: 10897860     EISSN: 1098898X     Source Type: Journal    
DOI: 10.1055/s-2007-984411     Document Type: Review

References (57)

1. Parsons TW III, Filzen TW. Evaluation and staging of musculoskeletal neoplasia. Hand Clin 2004;20:137-145
2. Peabody TD, Gibbs CP Jr, Simon MA. Current concepts review: evaluation and staging of musculoskeletal neoplasms. J Bone Joint Surg Am 1998;80:1204-1218
3. Sanders TG, Parsons TW III. Radiographic imaging of musculoskeletal neoplasia. Cancer Control 2001;8:221-231
4. Lodwick GS, Wilson AJ, Farrell C, Virtama P, Dittrich F. Determining growth rates of focal bone lesions from radiographs. Radiology 1980;134:577-583
5. Bataille R, Chevalier J, Rossi M, Sany J. Bone scintigraphy in plasma-cell myeloma: a prospective study of 70 patients. Radiology 1982;145:801-804
6. Otsuka N, Fukunaga M, Morita K, Ono S, Nagai K. Photon-deficient finding in sternum on bone scintigraphy in patients with malignant disease. Radiat Med 1990;8:168-172
7. Gilday DL, Ash JM. Benign bone tumors. Semin Nucl Med 1976;6:33-46
8. Mankin HJ. Chondrosarcoma of bone. In: Menendez LR, ed. Orthopaedic Knowledge Update: Musculoskeletal Tumors. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2002:187-194
9. Assoun J, Richardi G, Railhac JJ, et al. Osteoid osteoma: MR imaging versus CT. Radiology 1994;191:217-223
10. Hosalkar HS, Sumeet G, Moroz L, Pollock A, Dormans JP. The diagnostic accuracy of MRI versus CT imaging for osteoid osteoma in children. Clin Orthop Relat Res 2005; 433:171-177
11. Tehranzadeh J, Mnaymneh W, Ghavam C, Morillo G, Murphy BJ. Comparison of CT and MR imaging in musculoskeletal neoplasms. J Comput Assist Tomogr 1989; 13:466-472
12. Imhof H, Mang T. Advances in musculoskeletal radiology: multidetector computed tomography. Orthop Clin North Am 2006;37:287-298
13. Dupuy DE, Rosenberg AE, Punyaratabundhu T, Tan MH, Mankin HJ. Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol 1998; 171:759-762
14. Cheng EY, Thompson RC. New developments in the staging and imaging of soft-tissue sarcomas. Instr Course Lect 2000;49:443-451
15. Bonneville F, Cattin F, Marsot-Dupuch K, Dormont D, Bonneville JF, Chiras J. T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics 2006;26:93-113
16. de Kerviler E, Cuenod CA, Clement O, Halimi P, Frija G, Frija J. What is bright on T1 MRI scans? J Radiol 1998;79: 117-126
17. Bangert BA, Modic MT, Ross JS, et al. Hyperintense disks on T1-weighted MR images: correlation with calcification. Radiology 1995;195:437-443
18. Spiller M, Tenner MS, Couldwell WT. Effect of absorbable topical hemostatic agents on the relaxation time of blood: an in vitro study with implications for postoperative magnetic resonance imaging. J Neurosurg 2001;95:687-693
19. Gissel H, Despa F, Collins J, et al. Magnetic resonance imaging of changes in muscle tissues after membrane trauma. Ann NY Acad Sci 2005;1066:272-285
20. Gambarota G, Cairns BE, Berde CB, Mulkern RV. Osmotic effects on the T2 relaxation decay of in vivo muscle. Magn Reson Med 2001;46:592-599
21. Nissi MJ, Toyras J, Laasanen MS, et al. Proteoglycan and collagen sensitive MRI evaluation of normal and degenerated articular cartilage. J Orthop Res 2004;22:557-564
22. Antoniou J, Pike GB, Steffen T, et al. Quantitative magnetic resonance imaging in the assessment of degenerative disc disease. Magn Reson Med 1998;40:900-907
23. Van Dyck P, Vanhoenacker FM, Vogel J, et al. Prevalence, extension and characteristics of fluid-fluid levels in bone and soft tissue tumors. Eur Radiol 2006;16:2644-2651
24. May DA, Good RB, Smith DK, et al. MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients. Skeletal Radiol 1997;26:2-15
25. Tsushima Y, Endo K. Hypointensities in the brain on T2*-weighted gradient-echo magnetic resonance imaging. Curr Probl Diagn Radiol 2006;35:140-150
26. Eckhardt BP, Hernandez RJ. Pigmented villonodular synovitis: MR imaging in pediatric patients. Pediatr Radiol 2004;34:943-947
27. Rand T, Trattnig S, Male C, et al. Magnetic resonance imaging in hemophilic children: value of gradient echo and contrast-enhanced imaging. Magn Reson Imaging 1999;17: 199-205
28. Vande Berg BC, Malghem J, Lecouvet FE, Maldague B. Classification and detection of bone marrow lesions with magnetic resonance imaging. Skeletal Radiol 1998;27:529-545
29. Petren-Mallmin M. Clinical and experimental imaging of breast cancer metastases in the spine. Acta Radiol Suppl 1994;391:1-23
30. Ruzal-Shapiro C, Berdon WE, Cohen MD, Abramson SJ. MR imaging of diffuse bone marrow replacement in pediatric patients with cancer. Radiology 1991;181:587-589
31. Takagi S, Tanaka O, Miura Y. Magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes or leukemia. Blood 1995;86:316-322
32. Baur-Melnyk A, Buhmann S, Durr HR, Reiser M. Role of MRI for the diagnosis and prognosis ot multiple myeloma. Eur J Radiol 2005;55:56-63
33. Walde TA, Weiland DE, Leung SB, et al. Comparison of CT, MRI, and radiographs in assessing pelvic osteolysis: a cadaveric study. Clin Orthop Relat Res 2005;(437):138-144
34. Sofka CM, Potter HG, Figgie M, Laskin R. Magnetic resonance imaging of total knee arthroplasty. Clin Orthop Relat Res 2003;(406):129-135
35. Kolind SH, MacKay AL, Munk PL, Xiang QS. Quantitative evaluation of metal artifact reduction techniques. J Magn Reson Imaging 2004;20:487-495
36. Hodler J, Yu JS, Steinen HC, Resnick D. MR imaging versus alternative imaging techniques. Magn Reson Imaging Clin N Am 1995;3:591-608
37. Hosalkar HS, Garg S, Moroz L, Pollack A, Dormans JP. The diagnostic accuracy of MRI versus CT imaging for osteoid osteoma in children. Clin Orthop Relat Res 2005; (433):171-177
38. Hicks RJ, Toner GC, Choong PF. Clinical applications of molecular imaging in sarcoma evaluation. Cancer Imaging 2005;5:66-72
39. Townsend DW, Beyer T, Blodgett TM. PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med 2003; 33:193-204
40. Messa C, Landoni C, Pozzato C, Fazio F. Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms? J Nucl Med 2000;41:1702-1703
41. Adler LP, Blair HF, Makley JT, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991;32: 1508-1512
42. Kern KA, Brunetti A, Norton JA. Metabolic imaging of human extremity musculoskeletal tumors. J Nucl Med 1988; 29:181-186
43. Aoki J, Endo K, Watanabe H, et al. FDG-PET for evaluating musculoskeletal tumors: a review. J Orthop Sci 2003;8:435-441
44. Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the detection, grading and response to therapy of bone and soft tissue sarcomas: a systematic review and metaanalysis. Cancer Treat Rev 2004;30:83-101
45. Schulte M, Brecht-Kraus D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000;41:1695-1701
46. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001;219:774-777
47. Bredella MA, Caputo GR, Steinbach LS. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. AJR Am J Roentgenol 2002;179: 1145-1150
48. Hawkins DS, Rajendran JG, Conrad EU, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002;94:3277-3284
49. Schulte M, Brecht-Krauss D, Werner M, et al. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med 1999;40:1637-1643
50. Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000;25:874-881
51. Peterson JJ, Kransdorf MJ, O'Connor MI. Diagnosis of occult bone metastases: positron emission tomography. Clin Orthop Relat Res 2003;(415 suppl):S120-S128
52. Kneisl JS, Patt JC, Johnson JC, Zuger JH. Is PET useful in detecting occult nonpulmonary metastases in pediatric bone sarcomas? Clin Orthop Relat Res 2006;450:101-104
53. Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med 2005;35:135-142
54. Iagaru A, Chawla S, Menedez L, Conti PS. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun 2006;27:795-802
55. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996;78:656-663
56. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;(153):106-120
57. Green FL, Page DL, Fleming ID, et al. Bone. In: Green FL, American Joint Committee on Cancer, American Cancer Society eds. AJCC Cancer Staging Handbook. 6th ed. New York: Springer-Verlag; 2002:221-225